Anna Maria Di Giacomo

ScholarGPS® ID: 83220412419177

Affiliation

University of Siena, Siena, Italy

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

128

Predicted Citations

12,093

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
Phase 1 study of anti–immunoglobulin-like transcript 3 (ILT3) monoclonal antibody (mAb) MK-0482 + pembrolizumab (pembro) in patients with recurrent inoperable glioblastoma (GBM). (journal article) Kim, Tae Min \| Kim, Sang-We \| Gutierrez, Martin \| Di Giacomo, Anna Maria \| Voskoboynik, Mark \| Myer, Nicole \| Edmondson, Mackenzie \| Liu, Qi \| Chen, Mei \| Victoria, Iván Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 2046-2046 (2024). 10.1200/JCO.2024.42.16_suppl.2046 Cite \| Source
Safety and clinical efficacy of IOA-289, a novel autotaxin inhibitor, plus gemcitabine and nab-paclitaxel (GnP) in patients with previously untreated metastatic pancreatic ductal adenocarcinoma (mPDAC). (journal article) Melisi, Davide \| Quinzii, Alberto \| Valente, Monica \| Di Giacomo, Anna Maria \| Amato, Giovanni \| Simonetti, Elena \| Zecchetto, Camilla \| Casallino, Simona \| Leta, Luigi \| Messineo, Luisa \| ... \| Maio, Michele Journal of Clinical Oncology, volume 42, issue 16_suppl, pages e15130-e15130 (2024). 10.1200/JCO.2024.42.16_suppl.e15130 Cite \| Source
Immunotherapy in melanoma: Can we predict response to treatment with circulating biomarkers? (journal article) Splendiani, Elena \| Besharat, Zein Mersini \| Covre, Alessia \| Maio, Michele \| Di Giacomo, Anna Maria \| Ferretti, Elisabetta Pharmacology & Therapeutics, volume 256 (2024). 10.1016/j.pharmthera.2024.108613 Cited by (4) \| Cite \| Source
Immunotherapy in cutaneous melanoma and biologics in psoriatic disease: similarities and differences from a clinical multidisciplinary perspective (journal article) Roccuzzo, Gabriele \| Gherardi, Eleonora \| Maio, Michele \| Malagoli, Piergiorgio \| Marzano, Angelo Valerio \| Parodi, Aurora \| Pimpinelli, Nicola \| Spagnolo, Francesco \| Di Giacomo, Anna Maria \| Quaglino, Pietro Expert Opinion on Biological Therapy, volume 24, issue 3, pages 125-131 (2024). 10.1080/14712598.2024.2326168 Cited by (1) \| Cite \| Source
A phase II study of retifanlimab, a humanized anti-PD-1 monoclonal antibody, in patients with solid tumors (POD1UM-203) (journal article) Di Giacomo, A.M. \| Schenker, M. \| Medioni, J. \| Mandziuk, S. \| Majem, M. \| Gravis, G. \| Cornfeld, M. \| Ranganathan, S. \| Lou, S. \| Csoszi, T. ESMO Open, volume 9, issue 3, pages 102387- (2024). 10.1016/j.esmoop.2024.102387 Cite \| Source
Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches (journal article) Lofiego, Maria Fortunata \| Piazzini, Francesca \| Caruso, Francesca Pia \| Marzani, Francesco \| Solmonese, Laura \| Bello, Emma \| Celesti, Fabrizio \| Costa, Maria Claudia \| Noviello, Teresa \| Mortarini, Roberta \| ... \| Covre, Alessia Journal of Translational Medicine, volume 22, issue 1 (2024). 10.1186/s12967-024-05040-x Cited by (1) \| Cite \| Source
Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial (journal article) Di Giacomo, Anna Maria \| Chiarion-Sileni, Vanna \| Del Vecchio, Michele \| Ferrucci, Pier Francesco \| Guida, Michele \| Quaglino, Pietro \| Guidoboni, Massimo \| Marchetti, Paolo \| Simonetti, Elena \| Santangelo, Federica \| ... \| Maio, Michele European Journal of Cancer, volume 199 (2024). 10.1016/j.ejca.2024.113531 Cited by (2) \| Cite \| Source
The future of targeting cytotoxic T-lymphocyte-associated protein-4: Is there a role? (journal article) Di Giacomo, Anna Maria \| Lahn, Michael \| Eggermont, Alexander MM \| Fox, Bernard \| Ibrahim, Ramy \| Sharma, Padmanee \| Allison, James P. \| Maio, Michele European Journal of Cancer, volume 198 (2024). 10.1016/j.ejca.2023.113501 Cited by (2) \| Cite \| Source
Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream (journal article) Calabrò, Luana \| Bronte, Giuseppe \| Grosso, Federica \| Cerbone, Luigi \| Delmonte, Angelo \| Nicolini, Fabio \| Mazza, Massimiliano \| Di Giacomo, Anna Maria \| Covre, Alessia \| Lofiego, Maria Fortunata \| ... \| Maio, Michele Frontiers in Immunology, volume 14 (2024). 10.3389/fimmu.2023.1333661 Cited by (1) \| Cite \| Source
113P A multidisciplinary management of immune-checkpoint inhibitor (ICI)-related pneumonitis to improve its clinical management (journal article) Valente, M. \| Colucci, M. \| Vegni, V. \| Croce, V. \| Bellan, C. \| Rossi, G. \| Gibilisco, G. \| Frongia, F. \| Guazzo, R. \| Ghiribelli, C. \| ... \| Di Giacomo, A.M. Immuno-Oncology and Technology, volume 20 (2023). 10.1016/j.iotech.2023.100585 Cite \| Source
Nivolumab (NIVO) versus ipilimumab (IPI) dans le traitement adjuvant du mélanome opéré de stade III/IV : résultats à 7 ans de l’étude CheckMate 238 (journal article) Ascierto, P.A. \| Del Vecchio, M. \| Merelli, B. \| Gogas, H. \| Arance, A. \| Dalle, S. \| Cowey, C.L. \| Schenker, M. \| Grob, J.J. \| Chiarion-Sileni, V. \| ... \| Larkin, J. Annales de Dermatologie et de Vénéréologie - FMC, volume 3, issue 8, pages A339-A340 (2023). 10.1016/j.fander.2023.09.584 Cite \| Source
1089P Adjuvant nivolumab (NIVO) vs ipilimumab (IPI) in resected stage III/IV melanoma: 7-y results from CheckMate 238 (journal article) Ascierto, P.A. \| Del Vecchio, M. \| Merelli, B. \| Gogas, H. \| Arance Fernandez, A.M. \| Dalle, S. \| Cowey, C.L. \| Schenker, M. \| Grob, J.J. \| Chiarion Sileni, V. \| ... \| Larkin, J. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2223 Cited by (2) \| Cite \| Source
1084MO Nivolumab plus ipilimumab in melanoma patients with asymptomatic brain metastases: 7-year outcomes and quality of life from the multicenter phase III NIBIT-M2 trial (journal article) Di Giacomo, A.M. \| Chiarion Sileni, V. \| Del Vecchio, M. \| Ferrucci, P.F. \| Guida, M. \| Quaglino, P. \| Guidoboni, M. \| Marchetti, P. \| Simonetti, E. \| Amato, G. \| ... \| Maio, M. Annals of Oncology, volume 34 (2023). 10.1016/j.annonc.2023.09.2218 Cited by (1) \| Cite \| Source
Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial (journal article) Noviello, Teresa Maria Rosaria \| Di Giacomo, Anna Maria \| Caruso, Francesca Pia \| Covre, Alessia \| Mortarini, Roberta \| Scala, Giovanni \| Costa, Maria Claudia \| Coral, Sandra \| Fridman, Wolf H. \| Sautès-Fridman, Catherine \| ... \| Ceccarelli, Michele Nature Communications, volume 14, issue 1 (2023). 10.1038/s41467-023-40994-4 Cited by (7) \| Cite \| Source
Rational Use of Monoclonal Antibodies as Therapeutic Treatment in an Oncologic Patient with Long COVID (journal article) Cusi, Maria Grazia \| Di Giacomo, Anna Maria \| Anichini, Gabriele \| Gori Savellini, Gianni \| Terrosi, Chiara \| Gandolfo, Claudia \| Maio, Michele Viruses, volume 15, issue 3, pages 614- (2023). 10.3390/v15030614 Cite \| Source
From Co-Stimulation to Co-Inhibition: A Continuum of Immunotherapy Care Toward Long-Term Survival in Melanoma (journal article) Simonetti, Elena \| Cutarella, Serena \| Valente, Monica \| Sani, Tommaso \| Ravara, Matteo \| Maio, Michele \| Di Giacomo, Anna Maria OncoTargets and Therapy, volume Volume 16 (2023). 10.2147/OTT.S368408 Cited by (2) \| Cite \| Source
Immunotherapy for brain metastases and primary brain tumors (journal article) Di Giacomo, Anna M. \| Mair, Maximilian J. \| Ceccarelli, Michele \| Anichini, Andrea \| Ibrahim, Ramy \| Weller, Michael \| Lahn, Michael \| Eggermont, Alexander M.M. \| Fox, Bernard \| Maio, Michele European Journal of Cancer, volume 179 (2023). 10.1016/j.ejca.2022.11.012 Cited by (13) \| Cite \| Source
155P BNT113 + pembrolizumab as first-line treatment in patients with unresectable recurrent/metastatic HNSCC: Preliminary safety data from AHEAD-MERIT (journal article) Klinghammer, K. \| Saba, N.F. \| Castelluci, E. \| Colevas, A.D. \| Rutkowski, T. \| Greil, R. \| Thurner, D. \| Müller-Richter, U. \| Di Giacomo, A.M. \| Grewal, J. \| ... \| Sahin, U. Immuno-Oncology and Technology, volume 16 (2022). 10.1016/j.iotech.2022.100267 Cited by (4) \| Cite \| Source
12P Multi-omics correlation with clinical outcome in metastatic melanoma patients treated with ipilimumab plus guadecitabine: The NIBIT-M4 study (journal article) Di Giacomo, A.M. \| Noviello, T. \| Caruso, F.P. \| Scala, G. \| Ferraro, L. \| Covre, A. \| Coral, S. \| Anichini, A. \| Maio, M. \| Ceccarelli, M. Immuno-Oncology and Technology, volume 16 (2022). 10.1016/j.iotech.2022.100117 Cite \| Source
A novel microRNA signature for the detection of melanoma by liquid biopsy (journal article) Sabato, Claudia \| Noviello, Teresa Maria Rosaria \| Covre, Alessia \| Coral, Sandra \| Caruso, Francesca Pia \| Besharat, Zein Mersini \| Splendiani, Elena \| Masuelli, Laura \| Battistelli, Cecilia \| Vacca, Alessandra \| ... \| Ferretti, Elisabetta Journal of Translational Medicine, volume 20, issue 1 (2022). 10.1186/s12967-022-03668-1 Cited by (11) \| Cite \| Source